You just read:

Sanofi Announces Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) in Japanese People with Uncontrolled Diabetes

News provided by

Sanofi Diabetes

14 Jun, 2014, 18:03 BST